CoQ10 and Omega-3 as Adjuncts to Periodontal Therapy, TAC of Saliva.

NAEnrolling by invitationINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

April 20, 2024

Study Completion Date

May 10, 2024

Conditions
Periodontal Diseases
Interventions
DRUG

Receive 30 mg of Coq10

Group A received 30 mg of CoQ10, Group B was given 200 mg of Omega-3 daily supplements, and Group C did not receive any medication; after the two-month study period, teh clinical periodontal parameters were reassessed. Additionally, to compare teh total antioxidant capacity in saliva before and after teh intake of these supplements, as well as in patients who did not receive any medication, 2 ml of non-stimulated saliva was collected from each participant at teh beginning and end of teh study for analysis using UV-spectrophotometric methods, furthermore, teh following criteria determined teh selection of eligible participants for dis study.

DRUG

Non-Medicare Drugs

and Group C did not receive any medication; after the two-month study period, the clinical periodontal parameters were reassessed. Additionally, to compare teh total antioxidant capacity in saliva before and after teh intake of these supplements, as well as in patients who did not receive any medication, 2 ml of non-stimulated saliva was collected from each participant at teh beginning and end of teh study for analysis using UV-spectrophotometric methods, furthermore, teh following criteria determined teh selection of eligible participants for dis study.

Trial Locations (1)

1947833113

Amirhossein Farahmand, Tehran

All Listed Sponsors
lead

Amirhossein Farahmand

OTHER